A commonly reported symptom of Covid-19 infection has been loss of taste and smell. NIAID-funded researchers have found another sensory connection: SARS-CoV-2 can infect inner ear cells.
A clinical trial has found the combination of all-trans retinoic acid, which is a metabolite of vitamin A, and arsenic trioxide is highly effective in children with standard- and high-risk acute promyelocytic leukemia, or APL.
New evidence suggests that adding the targeted therapy ibrutinib (Imbruvica) to a standard chemotherapy regimen can improve how long some younger people with a specific form of diffuse large B-cell lymphoma (DLBCL) live.
Researchers found that a neglected antibiotic called hygromycin A selectively kills Borelliella burgdorferi, the bacteria that cause Lyme disease. The antibiotic was able to treat Lyme disease in mice without disrupting the microbiome.
NIH, FDA, 10 pharmaceutical companies and 5 nonprofit organizations have partnered to accelerate development of gene therapies for the 30 million Americans who suffer from a rare disease.
A commonly available FDA-approved oral diuretic pill may be a potential candidate for an Alzheimer’s disease treatment for those who are at genetic risk, according to findings published in Nature Aging.
Researchers report that a booster dose of the Moderna Covid-19 vaccine given to rhesus macaques enhanced their immune response, providing protection against all known circulating SARS-CoV-2 variants.
Overdose deaths involving methamphetamine nearly tripled from 2015 to 2019 among people ages 18-64 in the U.S., according to a NIDA study published in JAMA Psychiatry.
Children with hemiparetic cerebral palsy, a movement disorder that affects use of one side of the body, showed improved use of the arm and hand after receiving a high dose of Constraint-Induced Movement Therapy (CIMT) in a recent clinical trial.